Related Experiment Video

Updated: Aug 19, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

[Dialysis therapy in the Czech Republic in 1991]

J Lachmanová1, K Nĕmecek

  • 1Interní klinika 1. LF UK, Praha.

Casopis Lekaru Ceskych
|November 22, 1993
PubMed

Insights

In 1991, the Czech Republic treated 2064 patients with chronic renal failure, but faced challenges with aging equipment and a rising number of complex cases. This led to concerns about increased mortality and fewer transplant opportunities.

Area of Science:

  • Nephrology
  • Public Health

Context:

  • In 1991, 2064 patients with chronic renal failure (CRF) were treated across 43 hemodialysis centers in the Czech Republic.
  • The incidence of newly enlisted patients was high (655), yet the prevalence rate of 196.5 patients per million population remained below the European average.

Purpose:

  • To analyze the state of hemodialysis treatment for chronic renal failure in the Czech Republic in 1991.
  • To identify key challenges including technical equipment, patient demographics, and disease incidence.

Summary:

  • The Czech Republic's hemodialysis centers treated 2064 CRF patients in 1991, with 655 new cases. Despite this high influx, the patient-per-million rate was lower than the European average.
  • Concerns were raised regarding inadequate technical equipment, aging infrastructure, and a rising number of polymorbid and diabetic patients requiring dialysis.
  • The study noted a persistent high incidence of hepatitis and identified post-surgical complications and drug intoxication as leading causes for acute hemodialysis.

Impact:

  • The aging patient population and increasing comorbidities suggest a potential rise in mortality rates and a decrease in the number of patients eligible for kidney transplantation.
  • Inadequate technical infrastructure and equipment replacement pose significant challenges to the quality and efficiency of care for patients with chronic renal failure.
  • The high prevalence of hepatitis among dialyzed patients and the specific causes of acute renal failure highlight areas for targeted public health interventions and improved clinical management.

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Related Concept Videos

Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...